Abbott, GlaxoSmithKline deal

Abbott partnered with GlaxoSmithKline to co-develop and commercialize a PCR-based companion diagnostic for GSK's MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapy) for melanoma. The molecular diagno...